-
Cytokinetics (NASDAQ:CYTK) Earns "Overweight" Rating from Cantor Fitzgerald
Source: Buzz FX / 18 Oct 2024 08:17:13 America/Chicago
Cytokinetics (NASDAQ:CYTK) Earns "Overweight" Rating from Cantor Fitzgerald Written by MarketBeat October 18, 2024 Share Link copied to clipboard. Cytokinetics ( NASDAQ:CYTK - Get Free Report ) 's stock had its "overweight" rating reaffirme
Read more...